Barts Charity works to facilitate extensive and pioneering medical research and healthcare innovation, by working in close partnership with Barts Health NHS Trust and Queen Mary University of London. Through their grants and fundraising, they help to strengthen Barts Health and Queen Mary’s ability to embrace all that cutting-edge research and modern technology has to offer, transforming healthcare for their circa 2.5 million patient community.

With the support of Barts Charity investment, Barts Health’s hospitals and services are responding to the needs of East London’s patient community. From new robots to perform surgeries that have helped to reduce surgery times by 63 minutes at The Royal London Hospital, to a brand-new Breast Cancer Centre that will improve access to advanced breast surgery and reconstruction at St Batholomew's Hospital. At Queen Mary, researchers are gaining a greater understanding and developing new treatments and faster diagnostics for conditions particularly affecting local patients. To address the rising incidence of aggressive breast cancers in younger women, researchers are developing novel therapies targeting severe basal-like breast cancer. Where childhood vaccination uptake remains low, they are strengthening East London’s child vaccination programme. In response to elevated levels of heart disease, researchers are creating next generation cardiac medical devices at Barts Health’s Cardiovascular Development Hub. And research teams are developing new apps that expand access to genetic testing that could reduce health inequalities for global majority communities.

To help accelerate the latest healthcare innovations, world-class clinicians at Barts Health and leading researchers at Queen Mary, supported by Barts Charity, have come together to form the powerful Barts Life Sciences Partnership. This work culminates at the Barts Life Sciences Cluster in Whitechapel, providing space for researchers, scientists and clinicians to work directly alongside businesses and entrepreneurs to discover the healthcare solutions of tomorrow. East London’s diversity means it’s an important place to break new ground in health research and care – not only promoting health equity for an underrepresented local area but unlocking the potential for discoveries to be delivered across the UK and internationally. The Cluster’s location in Whitechapel also represents one of the most exciting new locations for a life sciences hub; strategically placed between Europe’s financial centre and London’s thriving start-up community.

Support through awareness raising, industry collaboration and philanthropy is vital to Barts Charity’s mission. It enables the acceleration of medical research, transformative patient care and solutions for some of the greatest health inequalities in the UK. The Anglonordic Life Science Conference brings together leaders in science, technology and investment from across the UK and Nordic regions, creating a powerful platform for collaboration and action. Its focus closely aligns with Barts Charity’s mission and with the world-leading expertise of Barts Life Sciences. As the partner for this year’s conference, Barts Charity has an opportunity to raise the profile of their ground-breaking medical research and galvanise support for their patients. As their local community is one of the most diverse places to call home, what makes a difference in East London has the potential to touch lives across the world, and will be of significant relevance to the international attendees at the 2026 Anglonordic Life Science conference.

"A cure for Parkinson's is needed urgently. Your support will enable us to continue funding the groundbreaking research that we passionately believe will deliver a cure. Cure Parkinson’s facilitates researchers and collaborates worldwide. Being the Anglonordic Charity of the Year would greatly enhance our ability to further foster and create new relationships within the Nordic and European drug discovery and technology industries as well as connect with patient advocates."

Cure Parkinson's